Clinically relevant variants in a large cohort of Indian patients with Marfan syndrome and related disorders identified by next-generation sequencing

[1]  R. Weber,et al.  Marfan syndrome and related connective tissue disorders in the current era in Switzerland in 103 patients: medical and surgical management and impact of genetic testing. , 2020, Swiss medical weekly.

[2]  M. Greally,et al.  Shprintzen-Goldberg syndrome , 2020, Definitions.

[3]  L. Drolsum,et al.  Marfan syndrome: Evolving organ manifestations—A 10‐year follow‐up study , 2019, American journal of medical genetics. Part A.

[4]  S. Blankenberg,et al.  Case-matched Comparison of Cardiovascular Outcome in Loeys-Dietz Syndrome versus Marfan Syndrome , 2019, Journal of clinical medicine.

[5]  G. Mortier,et al.  Biallelic variants p.Arg1133Cys and p.Arg1379Cys in COL2A1: Further delineation of phenotypic spectrum of recessive Type 2 collagenopathies , 2019, American journal of medical genetics. Part A.

[6]  L. Mannucci,et al.  Mutation analysis of the FBN1 gene in a cohort of patients with Marfan Syndrome: a 10-year single center experience. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[7]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[8]  D. Mitter,et al.  Next-generation sequencing of 32 genes associated with hereditary aortopathies and related disorders of connective tissue in a cohort of 199 patients , 2019, Genetics in Medicine.

[9]  G. Vriend,et al.  MetaDome: Pathogenicity analysis of genetic variants through aggregation of homologous human protein domains , 2019, bioRxiv.

[10]  Alexandros Kouris,et al.  VarSome: the human genomic variant search engine , 2018, bioRxiv.

[11]  M. Groenink,et al.  Results of next‐generation sequencing gene panel diagnostics including copy‐number variation analysis in 810 patients suspected of heritable thoracic aortic disorders , 2018, Human mutation.

[12]  A. Dalal,et al.  Exome sequencing reveals blended phenotype of double heterozygous FBN1 and FBN2 variants in a fetus. , 2018, European journal of medical genetics.

[13]  N. Cheshire,et al.  Targeted genetic analysis in a large cohort of familial and sporadic cases of aneurysm or dissection of the thoracic aorta , 2018, Genetics in Medicine.

[14]  B. Loeys,et al.  Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome. , 2017, Annals of cardiothoracic surgery.

[15]  J. Zhuang,et al.  Identification of Novel Clinically Relevant Variants in 70 Southern Chinese patients with Thoracic Aortic Aneurysm and Dissection by Next-generation Sequencing , 2017, Scientific Reports.

[16]  S. Adwani,et al.  A Case of Neonatal Marfan Syndrome: A Management Conundrum and the Role of a Multidisciplinary Team , 2017, Case reports in pediatrics.

[17]  R. Austin,et al.  MARFAN SYNDROME , 2018, Cassidy and Allanson's Management of Genetic Syndromes.

[18]  Gill Bejerano,et al.  M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity , 2016, Nature Genetics.

[19]  Trevor Hastie,et al.  REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. , 2016, American journal of human genetics.

[20]  C. Zamora,et al.  Loeys-Dietz syndrome. , 2016, Neurology India.

[21]  G. Jondeau,et al.  Homozygous and compound heterozygous mutations in the FBN1 gene: unexpected findings in molecular diagnosis of Marfan syndrome , 2016, Journal of Medical Genetics.

[22]  R. Płoski,et al.  Next-generation sequencing for diagnosis of thoracic aortic aneurysms and dissections: diagnostic yield, novel mutations and genotype phenotype correlations , 2016, Journal of Translational Medicine.

[23]  B. Loeys,et al.  TGF-β signalopathies as a paradigm for translational medicine. , 2015, European journal of medical genetics.

[24]  G. Vriend,et al.  SMAD2 Mutations Are Associated with Arterial Aneurysms and Dissections , 2015, Human mutation.

[25]  J. Elefteriades,et al.  Routine Genetic Testing for Thoracic Aortic Aneurysm and Dissection in a Clinical Setting. , 2015, The Annals of thoracic surgery.

[26]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[27]  Hui Yang,et al.  Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR , 2015, Nature Protocols.

[28]  J. Stoler,et al.  Clinical utility of a next generation sequencing panel assay for Marfan and Marfan‐like syndromes featuring aortopathy , 2015, American journal of medical genetics. Part A.

[29]  D. Roden,et al.  Performant Mutation Identification Using Targeted Next‐Generation Sequencing of 14 Thoracic Aortic Aneurysm Genes , 2015, Human mutation.

[30]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[31]  M. Goumans,et al.  Mutations in a TGF-β Ligand, TGFB3, Cause Syndromic Aortic Aneurysms and Dissections , 2015, Journal of the American College of Cardiology.

[32]  A. De Paepe,et al.  Gene panel sequencing in heritable thoracic aortic disorders and related entities – results of comprehensive testing in a cohort of 264 patients , 2015, Orphanet Journal of Rare Diseases.

[33]  Michelle S. Miller,et al.  The SMAD-binding domain of SKI: a hotspot for de novo mutations causing Shprintzen–Goldberg syndrome , 2014, European Journal of Human Genetics.

[34]  H. Bolz,et al.  Results of fibrillin-1 gene analysis in children from inbred families with lens subluxation. , 2014, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[35]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[36]  C. Lee,et al.  Homozygosity for a FBN1 missense mutation causes a severe Marfan syndrome phenotype , 2013, Clinical genetics.

[37]  P. Stenson,et al.  The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine , 2013, Human Genetics.

[38]  P. Robinson,et al.  In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome. , 2012, American journal of human genetics.

[39]  Seneca L. Bessling,et al.  Mutations in the TGF-β Repressor SKI Cause Shprintzen-Goldberg Syndrome with Aortic Aneurysm , 2012, Nature Genetics.

[40]  E. Fishman,et al.  Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm , 2012, Nature Genetics.

[41]  Jay Shendure,et al.  TGFB2 loss of function mutations cause familial thoracic aortic aneurysms and acute aortic dissections associated with mild systemic features of the Marfan syndrome , 2012, Nature Genetics.

[42]  B. Menten,et al.  Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys‐Dietz syndromes , 2011, Human mutation.

[43]  G. Vriend,et al.  Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis , 2011, Nature Genetics.

[44]  G. Pals,et al.  The Clinical Spectrum of Missense Mutations of the First Aspartic Acid of cbEGF-like Domains in Fibrillin-1 Including a Recessive Family , 2010, Human mutation.

[45]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[46]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[47]  Laurence Faivre,et al.  The revised Ghent nosology for the Marfan syndrome , 2010, Journal of Medical Genetics.

[48]  P. Ravaud,et al.  Comparison of Clinical Presentations and Outcomes Between Patients With TGFBR2 and FBN1 Mutations in Marfan Syndrome and Related Disorders , 2009, Circulation.

[49]  Chih-ping Chen,et al.  Mutation spectrum of the fibrillin‐1 (FBN1) gene in Taiwanese patients with Marfan syndrome , 2009, Annals of human genetics.

[50]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[51]  K. Rommel,et al.  Prevalence of dural ectasia in 63 gene‐mutation‐positive patients with features of Marfan syndrome type 1 and Loeys‐Dietz syndrome and report of 22 novel FBN1 mutations , 2009, Clinical genetics.

[52]  B. Giusti,et al.  FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations , 2008, Clinical genetics.

[53]  P. Robinson,et al.  A recurrent FBN1 mutation in an autosomal dominant ectopia lentis family of Indian origin. , 2007, Molecular vision.

[54]  M Claustres,et al.  Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. , 2007, American journal of human genetics.

[55]  G. Pals,et al.  Homozygosity for a FBN1 missense mutation: clinical and molecular evidence for recessive Marfan syndrome , 2007, European Journal of Human Genetics.

[56]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[57]  E. Arbustini,et al.  The FBN1 (R2726W) mutation is not fully penetrant , 2004, Annals of human genetics.

[58]  Gabor Matyas,et al.  Update of the UMD‐FBN1 mutation database and creation of an FBN1 polymorphism database , 2003, Human mutation.

[59]  P. Stenson,et al.  Human Gene Mutation Database (HGMD®): 2003 update , 2003, Human mutation.

[60]  R. Newcombe.  Two-sided confidence intervals for the single proportion: comparison of seven methods. , 1998, Statistics in medicine.

[61]  David Haussler,et al.  Improved splice site detection in Genie , 1997, RECOMB '97.

[62]  Peter G. Korning,et al.  Splice Site Prediction in Arabidopsis Thaliana Pre-mRNA by Combining Local and Global Sequence Information , 1996 .

[63]  L. Peltonen,et al.  A compound-heterozygous Marfan patient: two defective fibrillin alleles result in a lethal phenotype. , 1994, American journal of human genetics.

[64]  Ada Hamosh,et al.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.

[65]  S. Knudsen,et al.  Prediction of human mRNA donor and acceptor sites from the DNA sequence. , 1991, Journal of molecular biology.

[66]  G. Pals,et al.  Compound-heterozygous Marfan syndrome. , 2009, European journal of medical genetics.

[67]  Claude-Alain H. Roten,et al.  Theoretical and practical advances in genome halving , 2004 .

[68]  P. Stenson,et al.  Human Gene Mutation Database (HGMD , 2003 .

[69]  P. Robinson,et al.  The Application of Clinical Genetics Dovepress Perspectives on the Revised Ghent Criteria for the Diagnosis of Marfan Syndrome , 2022 .